LOS ANGELES (March 24, 2025) -- Cedars-Sinai surgical oncology experts will present innovative research and lead discussions on the latest advances in surgical techniques and novel therapies in cancer care at the upcoming Society of Surgical Oncology 2025 conference, taking place March 27-29 in Tampa, Florida.
“This conference provides an ideal platform for those dedicated to surgical oncology to share innovative treatment strategies and new research that drive progress in cancer care,” said Cristina R. Ferrone, MD, chair of the Jim and Eleanor Randall Department of Surgery at Cedars-Sinai and member of the Society of Surgical Oncology Executive Council. Ferrone will present opening remarks at the annual gathering and moderate a session titled “Best Papers I” showcasing top research papers in surgical oncology on March 28 from 8 to 9:30 a.m.
Ferrone, along with Alexandra Gangi, MD, interim director of the Division of Surgical Oncology at Cedars-Sinai and director of the Gastrointestinal Tumor Program at Cedars-Sinai Cancer, were in charge of planning and creating the program for this year’s annual meeting.
Mark Faries, MD, surgical director of the Melanoma Program in Cedars-Sinai Cancer and co-director of the Melanoma Program at The Angeles Clinic and Research Institute, will lead a session on March 28 on the latest research on melanoma, focusing on new treatments and surgical strategies to improve patient outcomes in this aggressive form of skin cancer.
Also making presentations during the conference:
Marc Attiyeh, MD, will discuss his work using genome sequencing to identify distinct subtypes of appendiceal cancer, which could lead to more targeted and personalized treatment approaches for patients.
Marissa Boyle, MD, will present an e-poster on the latest research on trends in breast and axillary surgeries in young patients with operable breast cancer from the National Cancer Database. She will also lead sessions on “Resident/Fellow Programming: Poster Presentations,” “Becoming a Surgical Oncologist,” and “Stressors in Your First Attending Job,” guiding future surgeons through fellowship matching and the challenges of transitioning into attending roles.
Shahrzad Arya, MD, will present her work on using CAR T-cell therapy to treat intrahepatic cholangiocarcinoma, a type of liver cancer, by harnessing the immune system to more effectively target and fight cancer cells.
Courtney Chen, MD, will examine temporal trends in mastectomy election and the rationale behind these decisions in young patients with ductal carcinoma in situ.
Teodora Dumitra, MD, will highlight research on using AI radiomic analysis to predict chemotherapy response in patients with colorectal liver metastasis.
Danielle Graham, MD, will present research on the use of neoadjuvant immunotherapy in breast cancer, highlighting the association with increased surgical complications in women undergoing this treatment.
Monica Justo, MD, will discuss her novel research on the role of methionine adenosyltransferase α2 in the development of colorectal liver metastasis.
Thomas Sutton, MD, will present two important studies: one examining how higher doses of radiation in neoadjuvant therapy impact survival rates in esophageal cancer, and another exploring gender-based differences in survival and disease progression for pancreatic cancer patients. Sutton will also present several e-posters that include findings on income-based survival disparities in metastatic gastrointestinal stromal tumors after generic imatinib.
Marco Ventin, MD, will discuss surgical and oncologic outcomes of open versus laparoscopic versus robotic parenchyma-sparing operations for pancreatic neuroendocrine tumors in a multi-institutional analysis.
Liti Zhang, MD, will present an updated global evaluation of rates and risk factors for pancreatic fistula after distal pancreatectomy.
CONTACT:
To schedule an interview with a Cedars-Sinai expert, contact Shishira Sreenivas at [email protected] or 202-297-0220.